Clinical Trials Directory

Trials / Completed

CompletedNCT02474953

A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product

A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Formulation to a Comparator Curcumin Product

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
KGK Science Inc. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is investigating the pharmacokinetic profile (i.e. the way the product is processed by the body) of a proprietary curcumin formulation compared to an unformulated curcumin product. Subjects will take a single dose of either the proprietary formulation or comparator product and the blood levels of curcumin and curcumin metabolites will be measured over a period of 48 hours.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProprietary Curcumin Formulation
DIETARY_SUPPLEMENTUnformulated Comparator Curcumin Product

Timeline

Start date
2015-04-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-06-18
Last updated
2015-09-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02474953. Inclusion in this directory is not an endorsement.